Adverse reactions to human plasma proteins range from mild urticaria to fatal anaphylaxis and may occur with virtually any blood product. The most common clinical settings appear to be whole blood transfusion in subjects with no previous history of reactions, or the infusion of fresh frozen plasma or injection of human immune serum globulin (HISG) to patients with known immunodeficiency.
The immunological processes involved and the management of reactions are discussed.
RingJ., StephanW., BrendelW.Anaphylactoid reactions to infusions of plasma protein and human serum albumin. Clin Allergy1979; 9: 89–97.
2.
AmmannA.J., FudenbergH.H.Immunodeficiency diseases. In Basic and Clinical Immunology. 2nd ed. Eds FudenbergH.H., StitesD.P., CaldwellJ.L., WellsJ.V.Lange Medical PublicationsCalifornia1978; 391.
3.
KingM.A., WellsJ.V., NelsonD.S.IgA synthesis by peripheral blood mononuclear cells from normal and selectively IgA deficient subjects. Clin Exp Immunol1979; 38: 306–315.
4.
WellsJ.V., McNallyM.P., KingM.A.Selective IgA deficiency in Australian blood donors. Pathology1978; 11: 313 (Abst.).
5.
LeiversS., ChristiansenF., FrenchM., DaveyM.G.Western Australian blood donors who lack immunoglobulin A. Proc Aust Soc Med Res1978; 11: 47 (Abst.).
6.
AmmannA.J., HongR.Selective IgA deficiency: presentation of 30 cases and a review of the literature. Medicine1971; 50: 223–236.
7.
WellsJ.V., MichaeliD., FudenbergH.H.Autoimmunity in selective IgA deficiency. In: Immunodeficiency in Man and Animals, Proceedings of the Second WHO International Workshop, The National Foundation-March of Dimes, New York1975; 144.
8.
WellsJ.V., BleumersJ.F., FudenbergH.H.Human anti-IgM iso-antibodies in subjects with selective IgA deficiency. Clin Exp Immunol1972; 12: 305–313.
9.
WellsJ.V., BleumersJ.F., FudenbergH.H.Immunobiology of human anti-IgM iso-antibodies. 1. Clinical and serologic studies. Clin Immunol Immunopath1973; 1: 257–269.
10.
StiehmE.R.Standard and special human immune serum globulins as therapeutic agents. Pediatrics1979; 63: 301–319.
11.
LeikolaJ., KoistinenJ., LehtinenM., VirolainenM.IgA-induced anaphylactic transfusion reactions: a report of four cases. Blood1973; 42: 111–119.
12.
KammeC., DahlquistE., JonssonS., LindstromF.IgG antibodies to IgA in two patients with hypogammaglobulinemia treated with commercial gammaglobulin. Acta Path Microbiol Scand1975; Sect C 83: 189–192.
13.
WellsJ.V., BuckleyR.H., SchanfieldM.S., FudenbergH.H.Anaphylactic reactions to plasma infusions in patients with hypogammaglobulinemia and anti-IgA antibodies. Clin Immunol Immunopath1977; 8: 265–271.
14.
AllenJ.C., KunkelH.G.Antibodies against gammaglobulin after repeated blood transfusions in man. J Clin Invest1966; 45: 29–33.
15.
FudenbergH.H., GoldE.R., VyasG.N., MacKenzieM.R.Human antibodies to human IgA globulins. Immunochemistry1968; 5: 203–206.
16.
VyasG.N., HolmdahlL., PerkinsH.A., FudenbergH.H.Serologic specificity of human anti-IgA and its significance in transfusion. Blood1969; 34: 573–581.
17.
NadorpJ.H.S., VossM., BuysW.C., Van MunsterP.J.J., Van TongerenJ.H.M., AalberseR.C., Van LoghemE.The significance of the presence of anti-IgA antibodies in individuals with an IgA deficiency. Europ J Clin Invest1973; 3: 317–323.
18.
VyasG.N., PerkinsH.A., YangY.M., BasantaniG.K.Healthy blood donors with selective absence of immunoglobulin A: prevention of anaphylactic transfusion reactions caused by antibodies to IgA. J Lab Clin Med1975; 85: 838–842.
19.
HoltP.D.J., TandyN.P., AnsteeD.J.Screening of blood donors for IgA deficiency: a study of the donor population in south-west England. J Clin Path1977; 30: 1007–1010.
20.
KoistinenJ., CardenasR.M., FudenbergH.H.Anti-IgA antibodies of limited specificity in healthy IgA deficient subjects. J Immunogenetics1977; 4: 295–300.
21.
RivatL., RivatC., DaveauM., RopartzC.Comparative frequencies of anti-IgA antibodies among anaphylactic transfusion reactions and among normal blood donors. Clin Immunol Immunopath1977; 7: 340–348.
22.
VyasG.N., FudenbergH.H.Immunobiology of human anti-IgA: a serological and immunogenetic study of immunisation to IgA in transfusion and pregnancy. Clin Genetics1971; 1: 45–61.
23.
AdamsL.S., JerryL.M.Detection of human IgA subclasses and allotypes by polymer-induced precipitation in agarose gel. J Immunol, Meth1974; 6: 157–164.
24.
Van LoghemE., WangA.C., ShusterJ.A.A new genetic marker of human immunoglobulins determined by an allele at the α2 locus. Vox Sang1976; 24: 481–486.
25.
Van LoghemE., de LangeG., KoistinenJ.The first isoallotype of human IgA proteins, Scand J Immunol1976; 3: 161–164.
26.
SchmidtA.T., TaswellH.F., GleichG.J.Anaphylactic transfusion reactions associated with anti-IgA antibody. N Engl J Med1969; 280: 188–193.
MillerW.V., HollandP.V., SugarbakerE., StroberW., WaldmannT.A.Anaphylactic reactions to IgA: a difficult transfusion problem. Amer J Clin Path1970; 54: 618–621.
29.
CooperN.R.The complement system. In Basic and Clinical Immunology, 2nd ed. Eds FudenbergH.H., StitesD.P., CaldwellJ.L., WellsJ.V.Lange Medical PublicationsCalifornia1978; 66.
30.
ArroyaveC.M., SchatzM., SimonR.A.Activation of the complement system by radiographic contrast media: studies in vivo and in vitro. J Allergy Clin Immunol1979; 63: 276–280.
31.
PinedaA.A., TaswellH.F.Transfusion reactions associated with anti-IgA antibodies: report of four cases and review of the literature. Transfusion1975; 15: 10–16.
32.
WadsworthC., HansonL.A.IgA in commercial-globulin preparations. Scand J Immunol1976; 5: 15–22.
33.
HenneyC.S., EllisE.F.Antibody production to aggregated human γG-globulin in acquired hypogammaglobulinemia. N Engl J Med1968; 278: 1144–1146.
34.
TurnerK.J., BartholomaeusW.N., TribeA., HobdayJ.D.Agammaglobulinaemia and anaphylactic shock. A case report and investigation of the mechanism. Aust NZ J Med1971; 1: 76–82.
35.
MackayM., ValletL., CombridgeB.S.The characterization and stability during storage of human immunoglobulin prepared for clinical use. Vox Sang1973; 25: 124–140.
36.
JanewayC.A., MerlerE., RosenF.S., SalmonS., CrainJ.D.Intravenous gamma globulin: metabolism of gamma globulin fragments in normal and agammaglobulinemic persons. N Engl J Med1968; 278: 919–923.
37.
BarandunS., SkvarilF., MorellA.Prophylaxis and treatment of diseases by means of immunoglobulins. Monographs Allergy1975; 9: 39–60.
38.
WellsJ.V., PennyR.Survival studies on a commercial preparation of intravenous human gammaglobulin labelled with 131I. Aust Ann Med1969; 18: 271–276.
